Ready to submit
Young Investigator
Qianjiang Young Investigator (Clinical Medicine)
The 2026 Qianjiang Young Investigator program in clinical medicine is now open to young cardiovascular clinical researchers and physicians across China, inviting solid clinical thinking and innovative research perspectives to QICC 2026.
A serious presentation may become the beginning of the next journey
The 2026 Qianjiang Young Investigator program in clinical medicine is now open to young cardiovascular clinical researchers and physicians across China, inviting solid clinical thinking and innovative research perspectives to QICC 2026.
4Submission types
OnlineOfficial submission system
QICC2026 Hangzhou presentation
Notice
Program Notice
A serious presentation may become the beginning of the next journey.
QICC believes that the future of cardiovascular medicine is written by young people working quietly in laboratories, operating rooms and clinical wards. The 20th Qianjiang Cardiovascular Conference (QICC 2026) will be held in Hangzhou from November 19 to 22, 2026.
As an annual academic meeting in cardiovascular medicine, QICC regards young talent development as one of its core values. Since its launch in 2021, Qianjiang Young Investigator has focused on one mission: finding young researchers and physicians whose work deserves to be seen by more people, and giving them a forum where they can be truly heard.
The 2026 Qianjiang Young Investigator (Clinical Medicine) program is now open. Selected applicants will be invited to present on site at QICC 2026.
October 25, 2026Application Deadline
https://www.qiccmd.com/sub/Submission Website
QICC 2026 On SiteInvited Presentation
Scope
Eligibility and Criteria
Eligibility
The program is open to researchers and clinicians engaged in cardiovascular clinical research across China.
Age and Qualification
Applicants should be under 45 years old on January 1 of the application year, hold a graduate degree and have an intermediate or higher professional title.
Innovative Work
In the past three years, the applicant should have led at least one searchable innovative research project in cardiovascular clinical research.
Research Value
The review emphasizes real clinical questions, research design quality, innovation and potential impact on clinical practice.
Materials
Application Materials
Applicants should complete online submission before October 25, 2026. Materials include curriculum vitae, a summary of innovative achievements in the past three years and supporting documents. The CV template can be downloaded from the website. The achievement summary should be within 500 Chinese characters or equivalent length.
For publications, submit copies of papers and proof of citation counts where applicable. For patents, provide evidence of patent translation or application. For projects or honors, provide copies of corresponding supporting documents.
Review Process
Selection Process
1. Application
Applicants complete online submission before October 25, 2026. The organizing committee will conduct an initial completeness review.
2. Expert Review
An academic review committee composed of domestic and international cardiovascular experts will conduct written review and invite selected applicants to present at the conference.
3. On-site Presentation
Selected applicants will present at QICC 2026 and be evaluated by an on-site expert panel.
4. Recognition
After final review, 1-2 Qianjiang Young Investigators and 2-4 nominees will be selected. Certificates will be issued by the organizing committee.
Submission
Contact
For questions, please contact the secretariat of the 20th Qianjiang Cardiovascular Conference. The program accepts online applications only. Email and paper materials are not accepted.
Submission InquiryRong 18868819849
Technical SupportFeng 18610065085 (WeChat same number)
Emailsub@qiccmd.com
We set no limits. Whether your research is just emerging or already systematic, if you bring solid clinical thinking and an innovative research perspective, there is a light reserved for you here.
Enter Submission System